FIRST AMENDMENT TO ASSET PURCHASE AND ASSIGNMENT AGREEMENTAsset Purchase and Assignment Agreement • April 5th, 2021 • Chemomab Therapeutics Ltd. • Pharmaceutical preparations
THIS FIRST AMENDMENT TO ASSET PURCHASE AND ASSIGNMENT AGREEMENT (the “Amendment”), is made effective as of the 31th day of March, 2021 (the “Amendment Date”) by and between Anchiano Therapeutics, Inc., a company organized under the laws of Delaware (“Anchiano”) and Kestrel Therapeutics, Inc., a company organized under the laws of Delaware (“Kestrel”; each of Anchiano and Kestrel, a “Party” and, together, the “Parties”).:
